70.44
1.48%
1.03
Finanzdaten der Insmed Inc-Aktie (INSM)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
9.79%
75.50
|
83.69 | 79.07 | 77.23 | 65.21 |
Cost Of Revenue |
5.35%
17.46
|
18.44 | 16.71 | 16.59 | 13.83 |
Gross Profit |
11.05%
58.04
|
65.25 | 62.37 | 60.63 | 51.38 |
Operating Expenses
|
16.41%
203.55
|
243.52 | 210.03 | 296.16 | 199.54 |
Interest Income/Expense |
1.24%
21.04
|
20.78 | 20.29 | 20.62 | 20.00 |
Benefits Costs and Expenses |
13.68%
232.00
|
268.76 | 237.46 | 321.51 | 224.50 |
Costs And Expenses |
15.64%
221.00
|
261.96 | 226.74 | 312.76 | 213.37 |
Operating Income/Loss |
18.38%
-145.50
|
-178.27 | -147.67 | -235.53 | -148.16 |
Income/Loss From Continuing Operations Before Tax |
15.43%
-156.50
|
-185.06 | -158.39 | -244.28 | -159.28 |
Income Tax Expense/Benefit, Deferred |
100.00%
-
|
-0.054 | - | - | - |
Income Tax Expense/Benefit |
40.98%
0.589
|
0.998 | 0.544 | 0.53 | 0.483 |
Income/Loss From Continuing Operations After Tax |
15.57%
-157.09
|
-186.06 | -158.93 | -244.81 | -159.76 |
Net Income/Loss
|
15.57%
-157.09
|
-186.06 | -158.93 | -244.81 | -159.76 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
9,978%
148.46
|
1.473 | 142.90 | 137.55 | 136.35 |
Diluted Average Shares |
9,978%
148.46
|
1.473 | 142.90 | 137.55 | 136.35 |
Basic Earnings Per Share |
17.19%
-1.06
|
-1.28 | -1.11 | -1.78 | -1.17 |
Diluted Earnings Per Share |
17.19%
-1.06
|
-1.28 | -1.11 | -1.78 | -1.17 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):